Advanced Medical Solutions Group (AMS) Share Price, News & Analysis

Company Overview

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.

Key Stats

• Today's Range: 250 to 255.50
• 50-Day Range: 191 to 262.61
• 52-Week Range: 185.60 to 272
• Volume: 1.46 million shs
• Average Volume: 1.44 million shs
• Market Capitalization: £551.66 million
• P/E Ratio: 56.27
• Dividend Yield: 1.14%
• Price Target: GBX 270.25
• Consensus Rating: Moderate Buy

Advanced Medical Solutions Group Stock Analysis - MarketRank™

Advanced Medical Solutions Group scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Advanced Medical Solutions Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and no sell ratings.

Upside/Downside

The consensus price target for Advanced Medical Solutions Group is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

Advanced Medical Solutions Group has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Advanced Medical Solutions Group is 56.27, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.46.

Price to Earnings Ratio vs. Sector

The P/E ratio of Advanced Medical Solutions Group is 56.27, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 20.68.

Price to Earnings Growth Ratio

Advanced Medical Solutions Group has a PEG Ratio of 5.00. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Advanced Medical Solutions Group has a P/B Ratio of 2.24. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for AMS.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Advanced Medical Solutions Group pays a meaningful dividend of 1.14%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Advanced Medical Solutions Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Advanced Medical Solutions Group is 59.29%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.2 / 5
• News Sentiment: N/A

News Sentiment

Advanced Medical Solutions Group has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.43 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Advanced Medical Solutions Group this week, compared to 0 articles on an average week.

Search Interest

Only 4 people have searched for AMS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Advanced Medical Solutions Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

4.11% of the stock of Advanced Medical Solutions Group is held by insiders.

Percentage Held by Institutions

22.55% of the stock of Advanced Medical Solutions Group is held by institutions.

Company Calendar

• Last Earnings: 3/18/2026
• Today: 5/11/2026

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Healthcare
• Current Symbol: LON:AMS
• CIK: N/A
• Web: www.admedsol.com
• Phone: +44-1606-863500
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Advanced Medical Solutions Group: GBX 270.25
• High Price Target: GBX 300
• Low Price Target: GBX 246
• Potential Upside/Downside: +6.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.75
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 4.52
• Trailing P/E Ratio: 56.27
• Forward P/E Ratio: 25.91
• P/E Growth: 5
• Net Income: £11.22 million
• Net Margins: 4.35%
• Pretax Margin: N/A
• Return on Equity: 3.87%
• Return on Assets: 2.35%

Debt

• Debt-to-Equity Ratio: 31.50
• Current Ratio: 2.79
• Quick Ratio: 4.58

Sales & Book Value

• Annual Sales: £228.94 million
• Price / Sales: 2.41
• Cash Flow: GBX 32.30 per share
• Price / Cash Flow: 7.87
• Book Value: GBX 113.37 per share
• Price / Book: 2.24

Miscellaneous

• Outstanding Shares: 216,914,000
• Free Float: N/A
• Market Cap: £551.66 million
• Optionable: Not Optionable
• Beta: 0.72